USD vs. CURE

Last updated Jun 9, 2026

USD (ProShares Ultra Semiconductors) and CURE (Direxion Daily Healthcare Bull 3x Shares) are both Leveraged Equities funds - USD tracks the Dow Jones U.S. Semiconductors Index (200%) while CURE tracks the Health Care Select Sector Index (300%). Both are passively managed. Over the past 10 years, USD returned 59.63%/yr vs 13.02%/yr for CURE. At a 0.43 correlation, their price movements are largely independent. USD charges 0.95%/yr vs 1.08%/yr for CURE.

Performance

USD vs. CURE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra Semiconductors (USD) and Direxion Daily Healthcare Bull 3x Shares (CURE). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, USD achieves a 81.60% return, which is significantly higher than CURE's -9.94% return. Over the past 10 years, USD has outperformed CURE with an annualized return of 59.63%, while CURE has yielded a comparatively lower 13.02% annualized return.

USD

• 1D: 7.41%
• 1M: -0.05%
• YTD: 81.60%
• 6M: 69.12%
• 1Y: 218.18%
• 3Y*: 115.96%
• 5Y*: 65.20%
• 10Y*: 59.63%

CURE

• 1D: -0.69%
• 1M: 18.27%
• YTD: -9.94%
• 6M: -3.58%
• 1Y: 30.33%
• 3Y*: 3.28%
• 5Y*: 1.60%
• 10Y*: 13.02%

*Multi-year figures are annualized to reflect compound growth (CAGR)

USD vs. CURE - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
USD ProShares Ultra Semiconductors	81.60%	62.08%	139.64%	228.79%	-68.57%	104.27%	68.16%	110.37%	-26.88%	81.72%
CURE Direxion Daily Healthcare Bull 3x Shares	-9.94%	22.55%	-8.47%	-9.40%	-20.51%	88.30%	5.02%	55.66%	2.82%	69.32%

Correlation

The correlation between USD and CURE is -0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.01
Correlation (3Y) Calculated over the trailing 3-year period	0.12
Correlation (5Y) Calculated over the trailing 5-year period	0.27
Correlation (10Y) Calculated over the trailing 10-year period	0.37
Correlation (All Time) Calculated using the full available price history since Jun 16, 2011	0.43

The correlation between USD and CURE shifts across timeframes, from -0.01 (1 year) to 0.43 (all time), reflecting how their relationship changes across market environments.

USD vs. CURE - Sectors Allocation Comparison

Sectors	USD	CURE
Financial Services	28.0%	-
Technology	26.7%	-
Energy	0.0%	-
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Healthcare	-	100.0%
Industrials	-	-
Real Estate	-	-
Utilities	-	-

Return for Risk

USD vs. CURE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

USD

USD Risk / Return Rank: 88
USD Sharpe Ratio Rank: 95
USD Sortino Ratio Rank: 79
USD Omega Ratio Rank: 81
USD Calmar Ratio Rank: 94
USD Martin Ratio Rank: 91

CURE

CURE Risk / Return Rank: 23
CURE Sharpe Ratio Rank: 22
CURE Sortino Ratio Rank: 26
CURE Omega Ratio Rank: 23
CURE Calmar Ratio Rank: 23
CURE Martin Ratio Rank: 21

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

USD vs. CURE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Semiconductors (USD) and Direxion Daily Healthcare Bull 3x Shares (CURE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	USD	CURE	Difference
Sharpe ratio: Return per unit of total volatility	3.43	0.69	+2.74
Sortino ratio: Return per unit of downside risk	3.15	1.30	+1.86
Omega ratio: Gain probability vs. loss probability	1.43	1.15	+0.29
Calmar ratio: Return relative to maximum drawdown	6.91	0.98	+5.93
Martin ratio: Return relative to average drawdown	19.73	2.24	+17.49
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

USD vs. CURE - Sharpe Ratio Comparison

The current USD Sharpe Ratio is 3.43, which is higher than the CURE Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of USD and CURE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	USD	CURE	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	3.43	0.69	+2.74
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.85	0.04	+0.82
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.86	0.26	+0.60
Sharpe Ratio (All Time) Calculated using the full available price history	0.47	0.48	0.00

Drawdowns

USD vs. CURE - Drawdown Comparison

The maximum USD drawdown since its inception was -88.63%, which is greater than CURE's maximum drawdown of -69.19%. Use the drawdown chart below to compare losses from any high point for USD and CURE.

Drawdown Indicators

	USD	CURE	Difference
Max Drawdown Largest peak-to-trough decline	-88.63%	-69.19%	-19.44%
Max Drawdown (1Y) Largest decline over 1 year	-31.80%	-31.10%	-0.70%
Max Drawdown (3Y) Largest decline over 3 years	-64.46%	-51.93%	-12.53%
Max Drawdown (5Y) Largest decline over 5 years	-77.85%	-52.23%	-25.62%
Max Drawdown (10Y) Largest decline over 10 years	-77.85%	-69.19%	-8.66%
Current Drawdown Current decline from peak	-16.10%	-28.51%	+12.41%
Average Drawdown Average peak-to-trough decline	-32.34%	-18.15%	-14.19%
Ulcer Index Depth and duration of drawdowns from previous peaks	11.11%	13.57%	-2.46%

Volatility

USD vs. CURE - Volatility Comparison

ProShares Ultra Semiconductors (USD) has a higher volatility of 28.47% compared to Direxion Daily Healthcare Bull 3x Shares (CURE) at 14.68%. This indicates that USD's price experiences larger fluctuations and is considered to be riskier than CURE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	USD	CURE	Difference
Volatility (1M) Calculated over the trailing 1-month period	28.47%	14.68%	+13.79%
Volatility (6M) Calculated over the trailing 6-month period	50.89%	31.01%	+19.88%
Volatility (1Y) Calculated over the trailing 1-year period	64.16%	44.18%	+19.98%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	77.00%	43.88%	+33.12%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	69.51%	49.60%	+19.91%

USD vs. CURE - Expense Ratio Comparison

USD has a 0.95% expense ratio, which is lower than CURE's 1.08% expense ratio.

Dividends

USD vs. CURE - Dividend Comparison

USD's dividend yield for the trailing twelve months is around 0.25%, less than CURE's 1.18% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
CURE Direxion Daily Healthcare Bull 3x Shares	1.18%	1.12%	1.17%	2.02%	0.38%	0.02%	0.17%	0.40%	0.70%	0.18%	0.00%	0.00%
USD ProShares Ultra Semiconductors	0.25%	0.39%	0.10%	0.05%	0.30%	0.00%	0.14%	0.72%	0.93%	0.32%	0.46%	0.39%

Frequently Asked Questions

Can I hold both USD and CURE in my portfolio?

USD and CURE have a correlation of -0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, USD or CURE?

USD has higher volatility (28.47%) compared to CURE (14.68%). In terms of maximum drawdown, USD dropped -88.63% vs CURE's -69.19%.

Which ETF is better, USD or CURE?

On 10-year performance, USD leads with 59.63% vs 13.02% for CURE. On fees, USD is cheaper at 0.95% per year. On volatility, CURE has been the lower-risk option at 14.68%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, USD or CURE?

Over the 10-year period, USD has performed better with a 59.63% return vs 13.02%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, USD or CURE?

USD is cheaper with a 0.95% expense ratio, compared with 1.08% for CURE.

Which ETF pays a higher dividend yield, USD or CURE?

CURE has the higher dividend yield at 1.18%, compared with 0.25% for USD.

What is the main difference between USD and CURE?

USD tracks Dow Jones U.S. Semiconductors Index (200%), while CURE tracks Health Care Select Sector Index (300%). They also come from different issuers: ProShares and Direxion. Their fees differ too: 0.95% for USD and 1.08% for CURE.

Which has better risk-adjusted returns?

USD currently has the higher Sharpe Ratio (3.43 vs 0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.